Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Portola studies oral Factor Xa inhibitor in knee replacement surgery patients

July 13, 2006

New coagulation factor Xa inhibitors prepared and tested

July 11, 2006

Recent patents report new anticoagulants for thrombotic disorders

June 29, 2006

Pivotal study of rhThrombin completes enrollment

June 23, 2006

New anticoagulants disclosed in recent patents

June 20, 2006

New anticoagulants for treating thrombotic disorders reported in recent Lilly and Portola patents

June 16, 2006

Phase II data for antithrombosis drug BAY-59-7939 support entry to phase III

June 15, 2006

Clinical Data targeting 2006 launch of genetic test for warfarin response

June 8, 2006

ATryn recommended for approval in Europe

June 7, 2006

Dabigatran safety assessed in long-term open-label follow-up study

June 1, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...